Related Experiment Video
Updated: May 11, 2026

Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Published on: September 16, 2019
Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression
Yi Yongjun1, Huang Shuyun, Chen Lei
1Department of Neurosurgery, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China.
Abstract:
Microglia, the immune cells of the brain, often present in large numbers in gliomas, where they promote tumor growth and invasiveness. This study found that atorvastatin reduced the pro-tumorigenic effects of microglia on glioma migration and invasion by reducing the microglial expression of membrane type 1 metalloproteinase (MT1-MMP). The results suggest that down-regulation of MT1-MMP is controlled by a p38 MAPK pathway in microglia. Taken together, the results support further research on atorvastatin as a candidate for glioma therapy by targeting microglia.
Insights
Atorvastatin inhibits microglia from promoting glioma growth by reducing MT1-MMP expression. This suggests atorvastatin may be a potential therapy for gliomas by targeting brain immune cells.
Area of Science:
- Neuroscience
- Immunology
- Oncology
Background:
- Microglia, the brain's immune cells, are abundant in gliomas.
- These microglia often enhance glioma progression and invasiveness.
Purpose of the Study:
- To investigate the effect of atorvastatin on microglia-mediated glioma cell migration and invasion.
- To elucidate the molecular mechanisms underlying atorvastatin's action on microglia in the context of glioma.
Main Methods:
- Assessing the impact of atorvastatin on microglial expression of membrane type 1 metalloproteinase (MT1-MMP).
- Investigating the role of the p38 MAPK pathway in regulating MT1-MMP expression in microglia.
Main Results:
- Atorvastatin significantly reduced the pro-tumorigenic effects of microglia on glioma migration and invasion.
- This reduction was associated with decreased microglial MT1-MMP expression.
- Down-regulation of MT1-MMP by atorvastatin in microglia is mediated by the p38 MAPK pathway.
Conclusions:
- Atorvastatin demonstrates potential in mitigating microglia-driven glioma advancement.
- Targeting microglial MT1-MMP expression via atorvastatin offers a promising therapeutic strategy for glioma treatment.

